SCHEMBL24670060

SCHEMBL24670060

NCc1nc2ccc(CCO)cc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 2/20 0.59
UBE2N P61088 1/20 0.59
IDO1 P14902 1/20 0.48
TDP1 Q9NUW8 2/20 0.46
MAPT P10636 3/20 0.45
PKM P14618 3/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
CACNA1H O95180 1/20 0.45
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
GFER P55789 1/20 0.45
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670085 0.88 RAD52 (0.63) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL24670057 0.79 RAD52 (0.52) RAD52UBE2NTDP1MAPTPKM
SCHEMBL20054433 0.75 AAK1 (0.52) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL15426717 0.74 RAD52 (0.50) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL29409142 0.73 TDP1 (0.70) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL4354084 0.73 TDP1 (0.70) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL38661663 0.73 IDO1 (0.76) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL19377986 0.73 HDAC3 (0.52) RAD52UBE2NIDO1TDP1MAPT
SCHEMBL4704614 0.73 HTR1A (0.59) MAPTKMT2AMEN1KDM4ERAB9A
Hydrochloric Acid SCHEMBL23705615 0.72 HDAC3 (0.51) RAD52UBE2NIDO1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed